Estimated reading time: 5 minutes
Table of contents
Introduction
North Carolina remains one of the few states without a medical cannabis program, despite strong support among voters. In recent years, the North Carolina Senate has passed medical cannabis legalization bills in both 2022 and 2023—most notably, a 36-10 supermajority in support of allowing qualified patients access to cannabis. However, these efforts have stalled in the House, leaving the state’s medical cannabis future uncertain as we look toward 2025.
Legislative Setbacks in the House
Both Senate bills failed to advance in the lower chamber. Former House Speaker Tim Moore explained that under his leadership, a bill could not proceed unless it had sufficient backing from his caucus. Even proposals with 100% Democratic support, but only 49% Republican backing, did not meet the threshold. Although the House recently elected a new speaker for the first time in 10 years, early signals are not optimistic for reform. Rep. Destin Hall, R-Caldwell—who has long opposed medical cannabis legalization—now holds the keys to the floor, potentially stalling future efforts.
Senate Support and Public Opinion
In contrast to the House, the upper chamber remains more receptive to reform. Senate President Pro Tempore Phil Berger, R-Guilford, has indicated openness to legalization—as long as any legislation addresses concerns regarding unregulated THC products derived from hemp. “It seems to me that there’s an opportunity there to address the medical marijuana issue at some point during the session,” Berger told Queen City News on January 29.
Senate Minority Leader Sydney Batch, D-Wake, has highlighted that medical cannabis, along with casinos, are nonpartisan issues the General Assembly could tackle. This sentiment is echoed by North Carolina voters: a September 2024 WRAL News poll found that 70% support medical cannabis legalization, and a February 2024 Meredith College survey reported 71% support.
Conclusion
With no cannabis legalization reform bills filed as of mid-February and the legislative session set to run through July 31, North Carolina remains one of eight states without a medical cannabis program—even when compared to states with very restrictive models like Texas. Meanwhile, the state’s 21-and-older population already has limited access to adult-use cannabis on the Eastern Band of Cherokee Indians’ reservation in the Qualla Boundary. As North Carolina heads into 2025, the future of Cannabis Legalization North Carolina hangs in the balance, with a divided House posing a significant obstacle despite robust Senate backing and widespread public support.
Cannabis Legalization North Carolina 2025 FAQs
No, recreational marijuana is not legal in North Carolina. It is only legal for limited medical use.
In the state of North Carolina, you cannot purchase cannabis from dispensaries without a medical card. The state’s medical cannabis program requires individuals to have a qualifying condition and possess a medical cannabis card to buy cannabis products legally.
Anyone over 21 with a valid ID can purchase THC products in Western North Carolina. Sales began Sept. 7, 2024 at 10 a.m. at the old bingo hall on the western end of the Qualla Boundary.
While North Carolina has yet to legalize recreational marijuana, there are strict prohibitions in place against the sale and distribution of cannabis, including the following: Sale 10 pounds or less: A Class I felony punishable by three to eight months imprisonment and a discretionary fine for a first offense.
No, you cannot buy marijuana in North Carolina for recreational use, except for limited medical use. Possession of 0.5 ounces or less is decriminalized for people with three or fewer misdemeanor convictions.
In the state of North Carolina the following medical conditions can qualify patients for a medical marijuana card are the following, positive status for human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), cancer, epilepsy, amyotrophic lateral sclerosis (ALS), Crohn’s disease, and more.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- New York Cannabis Provisional License (2026): From Provisional to Operational
For operators whose strength is growing cannabis, Virginia’s emerging adult-use market presents a significant opportunity – and a cultivation license is the gateway to it. The June 2026 framework authorizes the Virginia Cannabis Control Authority (CCA) to begin accepting license applications on or after February 1, 2027 and issuing licenses on or after May 1, 2027. It also establishes five cultivation tiers with maximum canopies ranging from 5,000 to 35,000 square feet. - New York Cannabis Proximity Rules (2026): Site Selection After the Correction
In New York cannabis retail, location is not a late-stage detail – it is a threshold licensing issue. A proposed dispensary can satisfy ownership and financial requirements and still fail because the site conflicts with a school, a house of worship, another dispensary, a municipal opt-out, or local zoning. The risk became unmistakable in 2025, when OCM concluded that its long-standing school-distance review did not match the wording of then-existing Cannabis Law § 72. - New York Cannabis Cultivation License & Canopy Expansion (2026)
For cultivators, New York in 2026 presents an unusual and genuinely interesting situation. The general application window is closed, but in March 2026 the Cannabis Control Board adopted Resolution 2026-19 directing OCM to process canopy-expansion amendment requests from existing adult-use cultivator licensees. The action followed OCM’s projection that the market could face a 356,000-pound supply gap in the 2026 growing season. - New York Processor Type 3 Branding License (2026): The Open White-Label Path
New York currently accepts Processor Type 3 Branding license applications year-round. For the right business, it can be an efficient way to establish a compliant brand presence in New York’s fast-growing adult-use market because it permits white-label agreements without requiring the brand licensee to operate a cannabis manufacturing facility. It does not, however, authorize the brand licensee to possess cannabis, manufacture products, distribute inventory, or sell directly to consumers. - New York Cannabis Microbusiness License (2026): The Limited-Vertical Path
In a market that otherwise generally separates the supply and retail tiers, the New York cannabis microbusiness license is a limited exception – and that makes it one of the most interesting and most misunderstood licenses in the state. It allows one small-scale operator to cultivate cannabis and conduct at least one additional authorized activity: processing, distribution, or retail sale. - How to Open a Dispensary in New York (2026): The Real Path Right Now
New York’s last adult-use application window closed in December 2023, and the Office of Cannabis Management (OCM) is still working through the roughly 7,000 applications it received then. That does not mean the door is shut – but it does mean the honest path into New York retail today looks very different from “fill out an application and wait.”